Form 4 Filing: Leheny A. Rachel Acquires Employee Stock Option

Leheny A. Rachel, Chief Executive Officer, Director, and Ten Percent Owner of CalciMedica, Inc., acquired 148,482 employee stock options on April 5, 2025. These options, exercisable at $0.5850 per share, are for CalciMedica's Common Stock. The options vest starting April 1, 2026, with 1/48th vesting monthly over four years, contingent upon the filing of a Form S-8 registration statement for shares added to the 2023 Equity Incentive Plan. The options expire on April 4, 2036. This transaction is reported on a Form 4 filing.